Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in EVGN — Evogene Ltd.

CIK 1446194 BALA CYNWYD, PA

Position in EVGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$35,234
-$4,644 QoQ
Shares Held
80,078
+1205.3% QoQ
Ownership
0.507%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 13 holders
Holding Since
Sep 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EVGN Over Time

Shares Held

Position Value (USD)

Derivatives in EVGN

reported options exposure · as of Mar 31, 2022
CallValue
$0
CallShares
0
PutValue
$13,390
PutShares
1,030

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,919,181 across 348 Biotechnology names. EVGN ranks #301 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EVGN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $35,234 80,078
2024-06-30 $39,878 61,351
2024-03-31 $24,371 32,495
2023-12-31 $20,437 24,330
2023-03-31 $7,730 12,271
2022-12-31 $10,046 14,352
2022-03-31 $17,161 13,201
2022-03-31 $13,390 10,300
2021-12-31 $63,304 38,600
2021-12-31 $85,383 52,063
2021-09-30 $155,232 58,800
2021-09-30 $26,400 10,000
2021-09-30 $174,775 66,203
2021-06-30 $150,674 44,057
2021-06-30 $133,380 39,000
2021-06-30 $51,642 15,100
2021-03-31 $96,768 19,200
2021-03-31 $320,040 63,500
2021-03-31 $286,781 56,901
2020-12-31 $124,000 26,383
2020-09-30 $60,627 15,310